BioTime (BTX) Tops Q1 EPS by 55c

BioTime (NYSE: BTX) reported Q1 EPS of $0.46, $0.55 better than the analyst estimate of ($0.09, may not compare). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $500 thousand.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c